Holen Sie sich die Stockscreener-App
9.63
15.00%
-1.70
Handel nachbörslich:
9.70
0.07
+0.73%
Schlusskurs vom Vortag:
$11.33
Offen:
$11.45
24-Stunden-Volumen:
32.43M
Relative Volume:
9.02
Marktkapitalisierung:
$2.29B
Einnahmen:
$510.17M
Nettoeinkommen (Verlust:
$146.93M
KGV:
16.08
EPS:
0.599
Netto-Cashflow:
$27.51M
1W Leistung:
-35.24%
1M Leistung:
-38.58%
6M Leistung:
-37.14%
1J Leistung:
-52.37%
1-Tages-Spanne:
$8.62
$11.45
1-Wochen-Bereich:
$8.62
$15.22
52-Wochen-Spanne:
$8.62
$25.67
Adma Biologics Inc Stock (ADMA) Company Profile
Firmenname
Adma Biologics Inc
Sektor
Branche
Telefon
(201) 478-5552
Adresse
C/O ADMA BIOLOGICS, INC., RAMSEY
Compare ADMA vs VRTX, REGN, ALNY, ARGX, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
9.63 | 2.70B | 510.17M | 146.93M | 27.51M | 0.599 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-07-19 | Fortgesetzt | Raymond James | Strong Buy |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2021-11-11 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-11-09 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-06-04 | Eingeleitet | Jefferies | Buy |
| 2019-04-15 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-07 | Fortgesetzt | H.C. Wainwright | Buy |
| 2017-12-11 | Bestätigt | Maxim Group | Buy |
| 2017-11-14 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2017-01-23 | Hochstufung | Maxim Group | Hold → Buy |
| 2016-08-01 | Herabstufung | Maxim Group | Buy → Hold |
| 2016-07-25 | Bestätigt | Maxim Group | Buy |
| 2015-05-13 | Bestätigt | Maxim Group | Buy |
| 2014-12-08 | Eingeleitet | Oppenheimer | Outperform |
| 2014-12-01 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Adma Biologics Inc Aktie (ADMA) Neueste Nachrichten
ADMA Biologics (NASDAQ:ADMA) Sees Strong Trading VolumeHere's What Happened - MarketBeat
Short Seller Report Alleges ADMA Biologics Financial Misrepresentation - Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
ADMA Biologics (ADMA) Shares Decline 12.6% - GuruFocus
ADMA Plummets Amid Market Challenges and Strategic Reforms - timothysykes.com
ADMA Biologics (ADMA) Responds to Short Report, Shares Drop 17% - GuruFocus
Down 27% in 4 Weeks, Here's Why Adma Biologics (ADMA) Looks Ripe for a Turnaround - Yahoo Finance UK
ADMA Biologics Responds to Negative Short Report - GuruFocus
ADMA Biologics responds to short seller report - Investing.com
ADMA Biologics Addresses Misleading Short-Seller Report - The Manila Times
New Strong Buy Stocks for March 25th - Yahoo Finance Singapore
ADMA Biologics (ADMA) Shares Drop 15% Following Short Report - GuruFocus
Assessing ADMA Biologics (ADMA) Valuation After Fresh Analyst Upgrades And Strong Buy Sentiment - Sahm
ADMA Biologics (NASDAQ:ADMA) Stock Price Down 8.7%What's Next? - MarketBeat
ADMA Stock Drops 17% After Culper Research Alleges Channel Stuffing - Stocktwits
ADMA stock drops 6% after Culper Research alleges channel stuffing - MSN
ADMA Shares Decline Amid Controversy Over Revenue Growth - GuruFocus
Adma Biologics Shares Drop After Short Report - Intellectia AI
ADMA Biologics shares plunge on short seller allegations - Investing.com
Culper Research Says We Are Short ADMA Biologics - TradingView
Adma Biologics stock hits 52-week low at 13.76 USD By Investing.com - Investing.com Australia
ADMA Biologics (NASDAQ:ADMA) Sets New 52-Week LowHere's Why - MarketBeat
Adma Biologics stock hits 52-week low at 13.76 USD - Investing.com
ADMA Biologics (ADMA) announces $200M capital return program including $125M ASR agreement - MSN
ADMA Biologics (ADMA) Announces $200M Capital Return Program Including $125M ASR Agreement - Yahoo Finance
10 Best NASDAQ Stocks Under $30 to Buy - Insider Monkey
(ADMA) Volatility Zones as Tactical Triggers - Stock Traders Daily
Tealwood Asset Management Inc. Invests $1.32 Million in ADMA Biologics Inc $ADMA - MarketBeat
Tealwood Asset Management Inc. Takes Position in ADMA Biologics Inc $ADMA - MarketBeat
Has The Pullback In ADMA Biologics (ADMA) Opened A New Valuation Opportunity? - Yahoo Finance
ADMA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
ADMA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Adma Biologics (ADMA) Advances While Market Declines: Some Information for Investors - Yahoo Finance
Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy? - Yahoo Finance
ADMA Biologics (NASDAQ:ADMA) Stock Price Down 8.1%Should You Sell? - MarketBeat
Adma Biologics (ADMA) upgraded to strong buy: Here's why - MSN
Technical Analysis: Will ADMA Biologics Inc face regulatory challenges2026 Highlights & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Adma Biologics CEO Grossman sells $318k in shares - Investing.com
ADMA Biologics (ADMA) CEO exercises options and sells 21K shares - Stock Titan
Why the market dipped but Adma Biologics (ADMA) gained today - MSN
Adma Biologics (ADMA) registers a bigger fall than the market: Important facts to note - MSN
ADMA Beats on Q2 Earnings and Revenues, Asceniv Drives Momentum - MSN
Tech Rally: Will ADMA Biologics Inc face regulatory challenges2026 Price Action Summary & Technical Pattern Alert System - baoquankhu1.vn
FDA-Approved Yield Boost For ASCENIV Might Change The Case For Investing In ADMA Biologics (ADMA) - Sahm
Zacks Industry Outlook Features Terns Pharmaceuticals, ADMA Biologics, ANI Pharmaceuticals, and Liquidia - Bitget
Zacks Industry Outlook Highlights Terns Pharmaceuticals, ADMA Biologics, ANI Pharmaceuticals and Liquidia - The Globe and Mail
HighVista Strategies LLC Invests $1.39 Million in ADMA Biologics Inc $ADMA - MarketBeat
First Light Asset Management LLC Buys 117,137 Shares of ADMA Biologics Inc $ADMA - MarketBeat
A Look At ADMA Biologics (ADMA) Valuation After Recent Share Price Swings - Yahoo Finance
Assessing ADMA Biologics (ADMA) Valuation After Recent Share Price Pullback And Mixed Performance Signals - simplywall.st
Boothbay Fund Management LLC Makes New $11.33 Million Investment in ADMA Biologics Inc $ADMA - MarketBeat
Finanzdaten der Adma Biologics Inc-Aktie (ADMA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Adma Biologics Inc-Aktie (ADMA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Grossman Adam S | President and CEO |
Mar 16 '26 |
Option Exercise |
5.40 |
15,000 |
81,000 |
2,133,777 |
| Grossman Adam S | President and CEO |
Mar 16 '26 |
Sale |
15.16 |
21,000 |
318,360 |
2,112,777 |
1.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):